Cargando…
Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway
The present study was designed to examine the protective effect of notoginsenoside R1 (NR1) on podocytes in a rat model of streptozotocin (STZ)-induced diabetic nephropathy (DN), and to explore the mechanism responsible for NR1-induced renal protection. Diabetes was induced by a single injection of...
Autores principales: | Huang, Guodong, Lv, Jianzhen, Li, Tongyu, Huai, Guoli, Li, Xiang, Xiang, Shaowei, Wang, Longlong, Qin, Zhenlin, Pang, Jianli, Zou, Bingyu, Wang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029967/ https://www.ncbi.nlm.nih.gov/pubmed/27571993 http://dx.doi.org/10.3892/ijmm.2016.2713 |
Ejemplares similares
-
Notoginsenoside R1 attenuates glucose-induced podocyte injury via the inhibition of apoptosis and the activation of autophagy through the PI3K/Akt/mTOR signaling pathway
por: Huang, Guodong, et al.
Publicado: (2017) -
Notoginsenoside R1 can inhibit the interaction between FGF1 and VEGFA to retard podocyte apoptosis
por: Li, ChangYan, et al.
Publicado: (2023) -
Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice
por: Lv, Zhimei, et al.
Publicado: (2018) -
Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway
por: Tian, Xue, et al.
Publicado: (2022) -
Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy
por: Chen, Yan, et al.
Publicado: (2019)